Authorities investigating bribery allegations related to medical marijuana rules could also determine the validity of a new claim that the Oklahoma Board of Pharmacy and its former director tampered with evidence in efforts to conceal misconduct. The pharmacy board recently released dozens of pages of emails to the Tulsa World in response to an Open Records Act request.
